logo
Select company
Select metric
$ -1.38EBIT per Share
VS
Market
18
Sector
43
Industry
55
History
88
$ 9.01Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -35.97M$ -1.38125.98M
3/31/2025$ -38.02M$ -1.47125.9M
12/31/2024$ -77.14M$ -4.46117.28M
9/30/2024$ -263.83M$ -12.29121.47M
6/30/2024$ -247.38M$ -14.79116.72M
3/31/2024$ -271.85M$ -50.2115.41M
12/31/2023$ -235.88M$ -45.6215.17M
9/30/2023$ -32.81M$ -6.3615.16M
6/30/2023$ -32.49M$ -6.3515.11M
3/31/2023$ -12.54M$ -2.4515.11M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -19.12.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average EBITPS has been $ -9.4.
  • The median EBITPS for CARTESIAN THERAPEUTICS INC during this period was $ -6.35
  • CARTESIAN THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ 11.23.
  • The lowest EBITPS recorded by CARTESIAN THERAPEUTICS INC in the same timeframe $ -50.21

CARTESIAN THERAPEUTICS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
HUMA : HUMACYTE INC $ -0.31NWBO : NORTHWEST BIOTHERAPEUTICS INC $ -0.05MREO : MEREO BIOPHARMA GROUP PLC $ -0.31INBX : INHIBRX BIOSCIENCES INC $ -10.21CRDF : CARDIFF ONCOLOGY INC $ -0.77BTAI : BIOXCEL THERAPEUTICS INC $ -4.45CATX : PERSPECTIVE THERAPEUTICS INC $ -1.3ADVM : ADVERUM BIOTECHNOLOGIES INC $ -8.75SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -3.38LSTA : LISATA THERAPEUTICS INC $ -2.31

Similar metrics to Shares WA:

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for CARTESIAN THERAPEUTICS INC is calculated as follows: EBIT [ $ -67.14M ] / (Shares WA [ 3.51M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -19.12 ]

RNAC - EBIT per Share, Last 5 years

$ -50.21

Minimum

Mar 31, 2024

$ 11.23

Maximum

Mar 31, 2022

$ -9.4

Average

$ -6.35

Median

EBITPS Benchmark Analysis

 The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.41.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.71
max$ 10.76
average$ 1.16
median$ 0.39
std$ 3.41